INTRODUCTION

Hepatitis B caused by Hepatitis B virus (HBV)
is becoming a global health issue with current estimates of 2 billion infected individuals and 387 million chronic carriers. Around one million HBV related deaths occur annually due to chronic hepatitis B, liver cirrhosis, liver decompensation and Hepatocellular carcinoma (HCC). 1 On the basis of prevalence of chronic hepatitis B around the globe, the world has been divided into three zones: high, intermediate and low prevalence zones. Pakistan falls in the area of intermediate prevalence zone with 2.5% of HBsAg positive population. 2 HBV infection is one of the major health issues in Pakistan. The main routes of transmission of HBV is parenteral, vertical(mother to child transmission) and horizontal (sexual). 3 The major mode of infection in endemic areas is vertical transmission that accounts for 50-60% of chronic carrier. Vertical transmission either in utero or peripartum remains a constant source of increase in the reservoir of chronically infected individuals. 4 The presence or absence of serological markers like HBsAg, HBeAg, Anti HBc, Anti HBs and Anti HBe are important in diagnosis, treatment planning and predicting the outcome of the disease. 5, 6 HBeAg is an important serological marker of HBV and is indicative of active viral replication. HBeAg positive carriers are regarded as a super carriers being highly infectious and are capable of transmitting the disease to others. They are kept under observation and are known candidates for antiviral treatment. mutation in precore region at nucleotide 1896 (Adenine is substituted for Guanine) leads to the production of a stop codon and terminates the production of HBeAg molecule. As a result no HBeAg is found in the serum of the patients and the condition is termed as HBeAg negative Chronic Hepatitis B (CHB) (7) . Loss of HBe antigen was first considered to be a good prognostic sign showing remission of hepatitis and suppression of HBV DNA. However with the advent of sensitive detection methods like PCR 8 , it showed that in a group of patients HBV DNA was detectable continuously or intermittently even in the absence of HBeAg. 9 Women of childbearing age with HBeAg positive are highly viremic and can transmit the disease to their newborns. However women who are HBeAg negative status might have active viral replication going on despite of their HBeAg negative serology with increased HBV DNA levels due to precore mutations in viral genome. 10 Around 90% of children born to these mothers with HBV DNA levels of more than 2000 IU/ml will develop chronic hepatitis B. 25% to 50% of children become infected before the age of 5 and another 5% in young adult hood as a result of post natal infection. 15-40% of these chronic carriers develop complications like HCC and liver cirrhosis. 11 This situation can only be prevented if active vaccination and immunoglobulins are administered in the first 12 hours of birth.
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Taking HBeAg negative hepatitis as non infectious is false sense of security which is the result of omitting an important parameter in HBV serology that is quantitative estimation of HBV DNA. Only HBV DNA estimation can decide whether virus is replicating or not. That is why this study was planned to compare HBV DNA values in HBeAg positive and negative female patients suffering from chronic hepatitis B in child bearing age by using PCR.
METHODOLOGY
Study Design
Cross sectional study.
Study Duration
Conducted from October 2014 to March 2015.
Sample Size
Samples were collected from 100 chronic hepatitis B females of child bearing. 
Study Setting
Inclusion Criteria
The inclusion criteria for the study were females of child bearing age and who had Hepatitis B surface antigen positive for more than 6 months
Exclusion Criteria
Those females who did not give consent or had co-infection with HCV were excluded from the study.
Data Collection Tool
Questionnaire.
Data Analysis SPSS version 17 was used to analyze data.
HBeAg (Cobas e 411 HBe Ag quantitative assay) was done by ELISA while Quantitative HBV DNA was extracted using INSTANT Virus DNA kit (AJ Roboscreen GmbH).
The data obtained was statistically analyzed by using the Statistical Package for the Social Sciences (SPSS) version 17.
RESULTS
Age
The mean age was 28.69 ± 6.83 years (Minimum age 17, Maximum 44 years). Age was divided into two groups, Group 1 (17- In HBeAg negative patients, a comparison was made between two groups of HBV DNA levels (i.e. HBV DNA ≤2000 IU/ml and ≥2000 IU/ml). It did not show any significant statistical difference (p=0.01), However 50% (n=42) of these patients had viral load more than 2000 IU/ml.
DISCUSSION
Hepatitis B virus (HBV) is commonly associated
with chronic carrier state especially in young age and children. This cross sectional study demonstrated that there is a very strong relationship between patients age, HBe positive status and HBV DNA Levels (p=0.02). Our study is consistent with other studies which show a higher percentage of HBeAg positivity in women of child bearing age thus making them more prone to transfer the disease to their off springs. 13 Transfer of HBV from mother to off spring is directly correlated with high levels of circulating viral DNA. 14, 15 HBeAg negative chronic hepatitis B was once thought to be uncommon in our region but studies from UK, Hong Kong, India and Pakistan shows the prevalence of HBe negative CHB was around (30%-60%) [16] [17] [18] A study that was conducted on 100 patients showed that 19% of patients with HBsAg positive status had HBeAg negative CHB. Another study conducted in Pakistan showed that 15% if HBeAg negative cases had high levels of HBV DNA due to the presence of pre core mutants. 19 The frequency of HBeAg negative CHB patients was higher in our study than in other studies. 20, 21 In our study 84% of the females with HBsAg positive status were HBeAg negative. These patients were also tested for HBV DNA. 50% of HBeAg negative women had high HBV DNA levels (more than 2000 IU/ml). A reliable HBV DNA cutoff value to distinguish between active CHB and inactive CHB is still not clear but according to EASL guidelines people who have HBV DNA levels of more than 2000 IU/ml must be given treatment irrespective of their HBeAg negative status. 22 4 Studies conducted have also concluded that such patients should be given treatment irrespective of their HBeAg status and ALT levels. 24, 25 This shows the importance of measurement of HBV DNA as it is critical for the diagnosis and management of HBeAg negative CHB. HBV DNA estimation through PCR is important and relevant in females of child bearing age for two major reasons: 1. Vertical transmission to baby during child birth may be prevented by appropriate preventive measures including safe antiviral treatment to the mother during last trimester, as decrease in maternal viremia is important as it lowers the risk of transmission to the new born. 26 2. The child born can be protected by giving active and passive vaccination during first 12 hours after birth. The high maternal HBV DNA level is the most important factor contributing to HBV perinatal transmission. [27] [28] [29] If vaccination is not given on time these children have a 90% chance of developing complication in 3 rd decade of life. 3. The attending doctors and medical staff should take all the required protective measures as these patients might be infectious.
It is also worth mentioning that in this study HBeAg positive cases were of lesser number i.e. only 16%. If only HBeAg is used as a sole marker of infectivity it will erroneously exclude a large number of HBeAg negative mothers with high circulating HBV DNA levels. Therefore it indicates that patients who are HBeAg negative should not be considered as less infectious as it may create a false feeling of "safety" in doctors and medical/ paramedical staff dealing with these patients and thus makes them prone to acquiring the infection by adopting a causal or careless approach of lesser precautions.
CONCLUSION
The findings of the present study strongly suggest that HBV DNA quantification is of utmost importance in HBsAg positive patients irrespective of their HBeAg status. Detail population studies are also important to determine the true prevalence of HBeAg negative CHB. HBeAg negative patients should be evaluated for detection of HBV DNA by PCR so that proper treatment can be given on time.
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